rs5727

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001039.4(SCNN1G):​c.*268G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.196 in 540,078 control chromosomes in the GnomAD database, including 11,359 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 3524 hom., cov: 32)
Exomes 𝑓: 0.19 ( 7835 hom. )

Consequence

SCNN1G
NM_001039.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.149

Publications

8 publications found
Variant links:
Genes affected
SCNN1G (HGNC:10602): (sodium channel epithelial 1 subunit gamma) Nonvoltage-gated, amiloride-sensitive, sodium channels control fluid and electrolyte transport across epithelia in many organs. These channels are heteromeric complexes consisting of 3 subunits: alpha, beta, and gamma. This gene encodes the gamma subunit, and mutations in this gene have been associated with Liddle syndrome. [provided by RefSeq, Apr 2009]
SCNN1G Gene-Disease associations (from GenCC):
  • Liddle syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • bronchiectasis with or without elevated sweat chloride 3
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • Liddle syndrome 2
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • pseudohypoaldosteronism, type IB1, autosomal recessive
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 16-23215737-G-A is Benign according to our data. Variant chr16-23215737-G-A is described in ClinVar as Benign. ClinVar VariationId is 318365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.242 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCNN1GNM_001039.4 linkc.*268G>A 3_prime_UTR_variant Exon 13 of 13 ENST00000300061.3 NP_001030.2 P51170A5X2V1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCNN1GENST00000300061.3 linkc.*268G>A 3_prime_UTR_variant Exon 13 of 13 1 NM_001039.4 ENSP00000300061.2 P51170

Frequencies

GnomAD3 genomes
AF:
0.212
AC:
32179
AN:
152020
Hom.:
3515
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.246
Gnomad AMI
AF:
0.198
Gnomad AMR
AF:
0.163
Gnomad ASJ
AF:
0.227
Gnomad EAS
AF:
0.0615
Gnomad SAS
AF:
0.0739
Gnomad FIN
AF:
0.231
Gnomad MID
AF:
0.190
Gnomad NFE
AF:
0.220
Gnomad OTH
AF:
0.207
GnomAD4 exome
AF:
0.190
AC:
73755
AN:
387940
Hom.:
7835
Cov.:
3
AF XY:
0.183
AC XY:
37701
AN XY:
205770
show subpopulations
African (AFR)
AF:
0.250
AC:
2782
AN:
11122
American (AMR)
AF:
0.129
AC:
2151
AN:
16622
Ashkenazi Jewish (ASJ)
AF:
0.236
AC:
2786
AN:
11828
East Asian (EAS)
AF:
0.0550
AC:
1384
AN:
25174
South Asian (SAS)
AF:
0.0846
AC:
3769
AN:
44572
European-Finnish (FIN)
AF:
0.227
AC:
5238
AN:
23068
Middle Eastern (MID)
AF:
0.174
AC:
288
AN:
1652
European-Non Finnish (NFE)
AF:
0.219
AC:
50813
AN:
231596
Other (OTH)
AF:
0.204
AC:
4544
AN:
22306
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
2553
5106
7660
10213
12766
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
234
468
702
936
1170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.212
AC:
32217
AN:
152138
Hom.:
3524
Cov.:
32
AF XY:
0.208
AC XY:
15489
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.246
AC:
10209
AN:
41502
American (AMR)
AF:
0.163
AC:
2487
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.227
AC:
786
AN:
3470
East Asian (EAS)
AF:
0.0612
AC:
317
AN:
5178
South Asian (SAS)
AF:
0.0740
AC:
357
AN:
4824
European-Finnish (FIN)
AF:
0.231
AC:
2444
AN:
10566
Middle Eastern (MID)
AF:
0.180
AC:
53
AN:
294
European-Non Finnish (NFE)
AF:
0.220
AC:
14932
AN:
67982
Other (OTH)
AF:
0.214
AC:
452
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1346
2692
4037
5383
6729
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
336
672
1008
1344
1680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.221
Hom.:
782
Bravo
AF:
0.207
Asia WGS
AF:
0.110
AC:
382
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 22, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Pseudohypoaldosteronism, type IB1, autosomal recessive Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Liddle syndrome 2 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
5.0
DANN
Benign
0.48
PhyloP100
0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5727; hg19: chr16-23227058; API